Skip to main content
Equibles

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 884546 SAN FRANCISCO, CA
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,137,391
-$1,883,173 QoQ
Shares Held
335,834
+2.3% QoQ
Ownership
0.765%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. TARS ranks #67 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,041,282 $1,013,966,007
2 REGN
Regeneron Pharmaceuticals, Inc.
 846,306 $527,705,642
3 RVMD
Revolution Medicines, Inc.
 1,917,025 $359,020,441
4 MRNA
Moderna, Inc.
 4,838,884 $338,867,045
5 ALNY
Alnylam Pharmaceuticals, Inc.
 755,377 $227,391,137
6 INCY
Incyte Corp
 1,692,439 $191,854,884
7 RPRX
Royalty Pharma plc
 3,083,528 $172,893,414
8 CYTK
Cytokinetics Inc
 1,565,781 $133,388,883

All Filings in TARS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,137,391 335,834
2026-03-31 $23,020,564 328,162
2025-12-31 $27,275,128 333,111
2025-09-30 $19,784,960 332,912
2025-06-30 $13,339,821 329,297
2025-03-31 $14,913,635 290,318
2024-12-31 $16,262,169 293,700
2024-09-30 $9,538,396 290,009
2024-06-30 $7,117,871 261,879
2024-03-31 $8,069,590 221,997
2023-12-31 $4,427,905 218,662
2023-09-30 $3,347,761 188,394
2023-06-30 $2,758,638 152,664
2023-03-31 $1,749,128 139,151
2022-12-31 $2,031,157 138,551
2022-09-30 $2,334,825 136,380
2022-06-30 $1,353,901 92,733
2022-03-31 $817,166 48,583
2021-12-31 $1,061,572 47,181
2021-09-30 $1,007,807 46,766
2021-06-30 $1,349,685 46,573
2021-03-31 $1,341,509 41,623
2020-12-31 $1,538,426 37,223